Aelin Therapeutics' Series A Round

Aelin Therapeutics raised a round of funding on December 11, 2017.

Aelin Therapeutics is a biotherapeutics company that is pioneering a novel modality in drug development in order to create a completely new class of antibiotics and first-in-class therapeutics against…

Articles about Aelin Therapeutics' Series A Round: